SPP1 and breast cancer: Of note, although the present investigation focuses on the selective effects of osteopontin-c, this splice variant is never expressed without the full-length variant osteopontin-a (untransformed breast epithelial cells may express no osteopontin or osteopontin-a alone, 75–80% of breast cancers express osteopontin-a plus osteopontin-c).